https://doi.org/10.4081/monaldi.2023.2667
Differences in nutritional status of patients with chronic obstructive pulmonary disease between Mediterranean and non-Mediterranean regions in Croatia
Submitted: June 16, 2023
Accepted: August 29, 2023
Published: September 13, 2023
Accepted: August 29, 2023
Abstract Views: 576
PDF_early view: 334
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
The nutritional status of patients with chronic obstructive pulmonary disease (COPD) is a significant factor that influences the prognosis of the disease. This observational study aimed to analyse the nutritional status of COPD patients and assess the associations between nutritional status, disease severity, and exercise capacity in four different regions of Croatia. In this multicentre study, 534 COPD patients were recruited and evaluated concerning fat-free mass (FFM), fat-free mass index (FFMI), skeletal muscle mass index (SMMI), phase angle (PhA), pulmonary function tests, and the 6-minute walk test (6MWT). There were 325 (60.9%) male and 209 (39.1%) female patients with a mean age of 66.7±8.4 years. Most patients (73.2%) exhibited a moderate to severely abnormal obstructive pattern and had a reduced 6MWT distance (396.5±110.8 m). Among the participants, 32.8% were overweight and 22.3% were obese, and they had satisfactory values for nutritional status variables (FFM, FFMI, SMMI, PhA). There were no statistical differences between the centres in terms of nutritional status variables. There was a significantly positive correlation of FEV1 with BMI (r=0.148, p=0.001), PhA (r=0.256, p=0.00), FFM (r=0.365, p=0.00), and SMMI (r=0.238, p=0.00). However, there was no significant correlation of the 6MWT with BMI (r=-0.049, p=0.254), FFM (r=0.065, p=0.133), and SMMI (r=-0.007, p=0.867). The data analysis demonstrated that our patients were not underweight and that there was no significant difference between the centres in terms of BMI, FFM, FFMI, SMMI, and PhA. This lack of significant difference was observed even though one of the regions studied was Mediterranean.
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for prevention, diagnosis and management of COPD: Report 2023.[Accessed March 6, 2023. Available from: https://goldcopd.org/2023-gold-report-2/
Halpin DMG, Celli BR, Criner GJ, et al. The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries. Int J Tuberc Lung Dis 2019;23:1131-41.
DOI: https://doi.org/10.5588/ijtld.19.0397
Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3: e442.
DOI: https://doi.org/10.1371/journal.pmed.0030442
Eisner MD, Blanc PD, Sidney S, et al. Body composition and functional limitation in COPD. Respir Res 2007;8:7.
DOI: https://doi.org/10.1186/1465-9921-8-7
Laviolette L, Sava F, O'Donnell DE, et al. Effect of obesity on constant work rate exercise in hyperinflated men with COPD. BMC Pulm Med 2010;10:33.
DOI: https://doi.org/10.1186/1471-2466-10-33
O'Donnell DE, Deesomchok A, Lam YM, et al. Effects of BMI on static lung volumes in patients with airway obstruction. Chest 2011;140:461-8.
DOI: https://doi.org/10.1378/chest.10-2582
Vozoris NT, O'Donnell DE. Prevalence, risk factors, activity limitation and health care utilization of an obese, population-based sample with chronic obstructive pulmonary disease. Can Respir J 2012;19:e18-24.
DOI: https://doi.org/10.1155/2012/732618
White JV, Guenter P, Jensen G, et al. Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition). JPEN J Parenter Enteral Nutr 2012;36:275-83.
DOI: https://doi.org/10.1177/0148607112440285
Vestbo J, Prescott E, Almdal T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006;173:79-83.
DOI: https://doi.org/10.1164/rccm.200506-969OC
Raad S, Smith C, Allen K. Nutrition status and chronic obstructive pulmonary disease: can we move beyond the body mass index? Nutr Clin Pract 2019;34:330-9.
DOI: https://doi.org/10.1002/ncp.10306
De Blasio F, Scalfi L, Di Gregorio A, et al. Raw bioelectrical impedance analysis variables are independent predictors of early all-cause mortality in patients with COPD. Chest 2019;155:1148-57.
DOI: https://doi.org/10.1016/j.chest.2019.01.001
Luo Y, Zhou L, Li Y, et al. Fat-free mass index for evaluating the nutritional status and disease severity in COPD. Respir Care 2016;61:680-8.
DOI: https://doi.org/10.4187/respcare.04358
Nguyen HT, Collins PF, Pavey TG, et al. Nutritional status, dietary intake, and health-related quality of life in outpatients with COPD. Int J Chron Obstruct Pulmon Dis 2019;14:215-26.
DOI: https://doi.org/10.2147/COPD.S181322
Mete B, Pehlivan E, Gülbaş G, Günen H. Prevalence of malnutrition in COPD and its relationship with the parameters related to disease severity. Int J Chron Obstruct Pulmon Dis 2018;13:3307-12.
DOI: https://doi.org/10.2147/COPD.S179609
Trichopoulou A, Kouris-Blazos A, Wahlqvist ML, et al. Diet and overall survival in elderly people. BMJ 1995;311:1457-60.
DOI: https://doi.org/10.1136/bmj.311.7018.1457
Fischer A, Johansson I, Blomberg A, Sundström B. Adherence to a Mediterranean-like diet as a protective factor against COPD: A nested case-control study. COPD 2019;16:272-7.
DOI: https://doi.org/10.1080/15412555.2019.1634039
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-7.
DOI: https://doi.org/10.1164/ajrccm.166.1.at1102
Kyle UG, Bosaeus I, De Lorenzo AD, et al. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr 2004;23:1430-53.
DOI: https://doi.org/10.1016/j.clnu.2004.09.012
NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet 2016;387:1377-96.
DOI: https://doi.org/10.1016/S0140-6736(16)30054-X
Medanić D, Pucarin-Cvetković J. [Pretilost – Javnozdravstveni Problem I Izazov - Obesity - Public health problem and challenge].[Article in Croatian]. Acta Medica Croat 2012;66:347-54.
Maslarda D, Bressan L. [Poremećaj u prehrani – pretilost: prehrambene navike, tjelesna aktivnosti i samoprocjena BMI u Hrvatskoj - Eating disorder - obesity: eating habits, physical activity and self-reported BMI in Croatia].[Article in Croatian]. J Appl Health Sci 2020;6:83-90.
DOI: https://doi.org/10.24141/1/6/1/9
Bhatta L, Leivseth L, Mai XM et al. GOLD classifications, COPD hospitalization, and all-cause mortality in chronic obstructive pulmonary disease: The HUNT study. Int J Chron Obstruct Pulmon Dis 2020;15:225-33.
DOI: https://doi.org/10.2147/COPD.S228958
Kahnert K, Alter P, Young D, et al. The revised GOLD 2017 COPD categorization in relation to comorbidities. Respir Med 2018;134:79-85.
DOI: https://doi.org/10.1016/j.rmed.2017.12.003
Le LAK, Johannessen A, Hardie JA, et al. Prevalence and prognostic ability of the GOLD 2017 classification compared to the GOLD 2011 classification in a Norwegian COPD cohort. Int J Chron Obstruct Pulmon Dis 2019;14:1639-55.
DOI: https://doi.org/10.2147/COPD.S194019
Varmaghani M, Dehghani M, Heidari E, et al. Global prevalence of chronic obstructive pulmonary disease: systematic review and meta-analysis. East Mediterr Health J 2019;25:47-57.
DOI: https://doi.org/10.26719/emhj.18.014
Putcha N, Drummond MB, Wise RA, Hansel NN. Comorbidities and chronic obstructive pulmonary disease: prevalence, influence on outcomes, and management. Semin Respir Crit Care Med 2015;36:575-91.
DOI: https://doi.org/10.1055/s-0035-1556063
Smith MC, Wrobel JP. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis 2014;9:871-88.
DOI: https://doi.org/10.2147/COPD.S49621
Cavaillès A, Brinchault-Rabin G, Dixmier A, et al. Comorbidities of COPD. Eur Respir Rev 2013;22:454-75.
DOI: https://doi.org/10.1183/09059180.00008612
Sabino PG, Silva BM, Brunetto AF. Nutritional status is related to fat-free mass, exercise capacity and inspiratory strength in severe chronic obstructive pulmonary disease patients. Clinics (Sao Paulo) 2010;65:599-605.
DOI: https://doi.org/10.1590/S1807-59322010000600007
James BD, Jones AV, Trethewey RE, Evans RA. Obesity and metabolic syndrome in COPD: Is exercise the answer? Chron Respir Dis 2018;15:173-181.
DOI: https://doi.org/10.1177/1479972317736294
Vrbica Ž, Vukić Dugac A, Popović Grle S, et al. [Smjernice Guidelines Preporuke za prevenciju i liječenje u bolesnika s kroničnom opstruktivnom plućnom bolesti - Recommendations for prevention and treatment of malnutrition in patients with chronic obstructive pulmonary disease].[Article in Croatian]. Liječnički Vjesnik 2018;140:183-9.
DOI: https://doi.org/10.26800/LV-140-7-8-24
How to Cite
Muršić, Davorka, Tajana Jalušić Glunčić, Jelena Ostojić, Sanda Škrinjarić Cincar, Ljiljana Bulat Kardum, Martina Dokoza, Nataša Karamarković Lazarušić, Erim Bešić, Miroslav Samaržija, and Andrea Vukić Dugac. 2023. “Differences in Nutritional Status of Patients With Chronic Obstructive Pulmonary Disease Between Mediterranean and Non-Mediterranean Regions in Croatia”. Monaldi Archives for Chest Disease, September. https://doi.org/10.4081/monaldi.2023.2667.
Copyright (c) 2023 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- R. D’Ippolito, A. Foresi, C. Castagnetti, S. Gesualdi, A. Castagnaro, E. Marangio, D. Olivieri, Indications for flexible fiberoptic bronchoscopy and its safety in the very elderly , Monaldi Archives for Chest Disease: Vol. 67 No. 1 (2007): Pulmonary series
- C. Zisis, S. Fragoulis, D. Rontogianni, G. Stratakos, I. Bellenis, Malignant triton tumour of the anterior mediastinum as incidental finding , Monaldi Archives for Chest Disease: Vol. 65 No. 4 (2006): Pulmonary series
- R. Drigo, A. Coin, M. Fontana, E. Enzo, A. Ferraresso, F. Zambotto, Partial flow/volume curves and airway resistances in obese subjects: new tools for investigating flow limitation? , Monaldi Archives for Chest Disease: Vol. 65 No. 2 (2006): Pulmonary series
- M. Lusuardi, Respiratory Medicine in general practice: what is the role of the pulmonary specialist? , Monaldi Archives for Chest Disease: Vol. 63 No. 1 (2005): Pulmonary series
- P. Vitulo, Current status and perspectives in lung transplantation , Monaldi Archives for Chest Disease: Vol. 61 No. 4 (2004): Pulmonary series
- The Publisher, Correction. Subtyping of advanced lung cancer based on PD-L1 expression, tumor histopathology and mutation burden (EGFR and KRAS): a study from North India , Monaldi Archives for Chest Disease: Vol. 93 No. 4 (2023)
- Vincenzo Russo, Anna Rago, Nunzia Laezza, Pierpaolo Di Micco, Laura Giannetti, Luigi Atripaldi, Antonio D'Onofrio, Paolo Golino, Gerardo Nigro, Edoxaban in elderly patient with morbid obesity and atrial fibrillation: the role of plasma levels evaluation for selecting the appropriate dose , Monaldi Archives for Chest Disease: Vol. 90 No. 1 (2020)
- Matilde Boccia, Luigi Aronne, Benito Celia, Grazia Mazzeo, Maria Ceparano, Vito D'Agnano, Roberto Parrella, Tullio Valente, Andrea Bianco, Fabio Perrotta, COVID-19 and coagulative axis: review of emerging aspects in a novel disease , Monaldi Archives for Chest Disease: Vol. 90 No. 2 (2020)
- Gianluigi Balestroni, Giovanna Omarini, Pierangela Omarini, Massimo Pistono, Ugo Corrà , Marco Gnemmi, Pantaleo Giannuzzi, Left ventricular assist device: which emotional impact on the patient? , Monaldi Archives for Chest Disease: Vol. 82 No. 2 (2014): Cardiac series
- C.A. Jiménez-Ruiz, K.O. Fagerström, Smoking cessation treatment for COPD smokers: the role of counselling , Monaldi Archives for Chest Disease: Vol. 79 No. 1 (2013): Pulmonary series
<< < 77 78 79 80 81 82 83 84 85 86 > >>
You may also start an advanced similarity search for this article.
